Finding suggests novel ways to boost vaccination or natural defenses
Our bodies rely on the production of potent, or 'high affinity', antibodies to fight infection. The process is very complex, yet Sydney scientists have discovered that it hinges on a single molecule, a growth factor, without which it cannot function. There is much we do not yet understand about our immune system. In simple terms, our bodies produce B cells, which make antibodies, and T cells, which help them. Ways in which these cells operate and interact with each other are still coming to light.
Roughly eight years ago, a new subset of T cells, T follicular helper (TFH) cells, was identified. This important class of T cells operates in specific environments termed 'germinal centres', specialised areas within lymph organs where B cells proliferate to form high affinity antibodies whenever we fight infection. TFH cells play a critical role in that they communicate with, and help activate, B cells.
The novel finding made by Dr Cecile King and PhD student Alexis Vogelzang, from the Garvan Institute of Medical Research in Sydney, was that the molecule interleukin 21 (IL-21) is a growth factor for TFH cells. A paper detailing this finding was published online today in the prestigious international journal Immunity.
A cytokine, or chemical messenger, IL-21 is already well known to immunologists. While its newly identified growth factor role is only one of several functions, that function is fundamental. Without IL-21, the all-important TFH cells could neither develop nor survive.
Dr Cecile King, head of the Mucosal Autoimmunity Group at Garvan, has been investigating the roles of IL-21 for several years. "We already knew that IL-21 was produced by TFH cells and that it was a major initiator of proliferation in B cells," she said. "We were surprised to find that TFH cells not only produce IL-21, they also absolutely need it to survive and they utilise it to function."
"We showed that if you take a mouse genetically deficient in IL-21 and immunise it, you don't get TFH cells and you don't get antibody production. Conversely, if you put IL-21 receptor sufficient, or normal, T cells into the same mouse, where of course the B cells remain abnormal, you recover the normal immune reaction."
"These specialised T cells are thought to be the ones that direct traffic. They are the only ones that can move into the B cell zone and initiate high affinity antibody production."
"Without IL-21, we probably wouldn't be completely immunodeficient, just severely compromised. In addition to the high affinity antibodies we're talking about, our bodies also produce a lot of low affinity antibodies for mopping up infection. That low level response happens around-the-clock and is one of our body's first lines of defence."
"You could say that IL-21 directs the most finely-tuned aspect of our immune response. The highly specialised weaponry developed on-the-spot to target aggressive invaders."
"This finding suggests novel ways to boost vaccination or natural defences."
Source: Research Australia
Related
- Princeton team's analysis of flu virus could lead to better vaccinesTue, 12 May 2009, 16:21:45 EDT
- La Jolla Institute discovers genetic trigger for disease-fighting antibodiesThu, 16 Jul 2009, 14:39:55 EDT
- Method for fast human antibodies against flu could find broad useWed, 30 Apr 2008, 17:00:25 EDT
- NIAID media availability: New strategy proposed for designing antibody-based HIV vaccineSun, 14 Jun 2009, 14:35:45 EDT
- New hope for HIV treatment: Cells exhausted from fighting HIV infection can be revitalizedMon, 10 Nov 2008, 17:51:00 EST
Other sources
- Immunity relies on single growth factorfrom Science AlertMon, 7 Jul 2008, 20:14:08 EDT
- Novel Ways To Boost Vaccination Or Natural Defensesfrom Science DailyMon, 7 Jul 2008, 10:35:33 EDT
- Novel ways to boost vaccination or natural defencesfrom Science CentricMon, 7 Jul 2008, 10:35:10 EDT
- Finding suggests novel ways to boost vaccination or natural defensesfrom PhysorgMon, 7 Jul 2008, 10:14:20 EDT
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Learn more about
Popular science news articles
- Transcendental Meditation helped heart disease patients lower cardiac disease risks by 50 percent
- Nanoparticles used in common household items caused genetic damage in mice
- Boehringer Ingelheim announces Phase III data of flibanserin in pre-menopausal women with HSDD
- Heart disease found in Egyptian mummies
- Therapy 32 times more cost effective at increasing happiness than money
No popular news yet
- Nanoparticles used in common household items caused genetic damage in mice
- Treatment with folic acid, vitamin B12 associated with increased risk of cancer, death
- New study links vitamin D deficiency to cardiovascular disease and death
- Therapy 32 times more cost effective at increasing happiness than money
- Continuous chest compression-CPR improved cardiac arrest survival in Arizona